HEPANOSTIKA(TM) ANTI-HAV MIDROELISA SYSTEM

FDA Premarket Approval P830018

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

DeviceHEPANOSTIKA(TM) ANTI-HAV MIDROELISA SYSTEM
Generic NameHepatitis A Test (antibody And Igm Antibody)
ApplicantORGANON TEKNIKA CORP.
Date Received1983-04-05
Decision Date1989-02-06
Notice Date1989-04-17
PMAP830018
SupplementS
Product CodeLOL 
Docket Number89M-0057
Advisory CommitteeMicrobiology
Expedited ReviewNo
Combination Product No
Applicant Address ORGANON TEKNIKA CORP. 100 Akzo Ave. durham, NC 27712

Supplemental Filings

Supplement NumberDateSupplement Type
P830018Original Filing
S001 1989-08-25 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.